Medical Technology Company BD Gains Strategic View of $400 Million R and D Portfolio

tadhaas Reading with interest from Tads case studies how Medical technology company BD (Becton, Dickinson and Company) serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. While R&D spending at BD grew rapidly, the company’s ability to analyze projects and investments lagged behind. BD needed a tool that would provide a companywide view of all projects, associated costs, and resources.

For further reading see

Comments (0)

Skip to main content